Clinical Trial Update: HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating recurrence after direct-acting antivirals in hepatitis C-related hepatocellular carcinoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Snippet

Sponsor: Alexandria University | Conditions: Hepatocellular Carcinoma, Hepatitis C | Phase 4 | Status: COMPLETED